GlassScriptPhysician profile
Alexander Harris
NPI 1700236635
$2,030.14
in general payments reported to CMS, 2019-2025
17 companies · $739 in 2025
The $739 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $153 · 2021: $71.12 · 2022: $45.92 · 2023: $191 · 2024: $830 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235 · Consulting Fee: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.33 |
| Consulting Fee | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $577.21 | 2024-2025 | Imfinzi |
| Teleflex LLC | $302.76 | 2025 | Barrigel |
| Boston Scientific Corporation | $200.38 | 2021-2025 | Spaceoar System, Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $172.20 | 2023-2025 | |
| Novocure INC. | $142.49 | 2025 | Optune Gio |
| Varian Medical Systems, INC. | $133.75 | 2020 | |
| Merck Sharp & Dohme LLC | $108.27 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $101.55 | 2024-2025 | |
| Blue Earth Diagnostics | $74.93 | 2025 | Posluma |
| Sumitomo Pharma America, INC. | $47.48 | 2023-2024 | Orgovyx |
| Penumbra, INC. | $33.79 | 2021 | |
| Cardinal Health 414 LLC | $28.96 | 2025 | |
| Tactile Systems Technology INC | $26.15 | 2021 | |
| Sirtex Medical INC | $23.86 | 2023 | Sir-Spheres Microspheres |
| Myriad Genetic Laboratories, INC. | $23.59 | 2024 | Myrisk |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $19.02 | 2020 | |
| Lilly USA, LLC | $13.75 | 2023 | Verzenio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.